Similar articles

• Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated?

  Trichon BH, O'Connor CM. Trichon BH, et al. Am Heart J. 2002 Sep;144(3):373-6. doi: 10.1067/mhj.2002.123576. Am Heart J. 2002. PMID: 12228770 Review. No abstract available.
• Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation.

  Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper G 4th, Carabello BA. Tsutsui H, et al. J Clin Invest. 1994 Jun;93(6):2639-48. doi: 10.1172/JCI117277. J Clin Invest. 1994. PMID: 7911128 Free PMC article.
• Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction.

  Agricola E, Ielasi A, Oppizzi M, Faggiano P, Ferri L, Calabrese A, Vizzardi E, Alfieri O, Margonato A. Agricola E, et al. Eur J Heart Fail. 2009 Jun;11(6):581-7. doi: 10.1093/eurjhf/hfp051. Epub 2009 Apr 27. Eur J Heart Fail. 2009. PMID: 19398488
• Afterload reduction may halt and beta-adrenergic blockade may worsen progression of left ventricular dysfunction in patients with chronic compensated mitral regurgitation: a retrospective cohort study.

  Oh SH, Meyers DG. Oh SH, et al. Angiology. 2007 Apr-May;58(2):196-202. doi: 10.1177/0003319707300357. Angiology. 2007. PMID: 17495269
• [Severe mitral regurgitation with ejection fraction below 40%: pharmacologic therapy is the treatment of choice].

  Rothlin ME. Rothlin ME. Schweiz Med Wochenschr. 1997 Dec 6;127(49):2035-9. Schweiz Med Wochenschr. 1997. PMID: 9476303 Review. German.